Search results
Results from the WOW.Com Content Network
Atorvastatin is a statin medication used to prevent cardiovascular disease in those at high risk and to treat abnormal lipid levels. [4] For the prevention of cardiovascular disease, statins are a first-line treatment. [4] It is taken by mouth. [4] Common side effects include joint pain, diarrhea, heartburn, nausea, and muscle pains. [4]
[27] [28] [29] While used off-label for male pattern hair loss in most of the world, dutasteride is specifically approved for this indication in South Korea and Japan. [30] [31] There is tentative support for spironolactone in women. [14] Due to its feminising side effects and risk of infertility it is not often used by men.
Changes in hair: You may start to notice thinning, hair loss, brittleness, or dryness. Changes in skin : This often looks like noticeable dryness, flaky, or scaly skin, especially around the eyes ...
Hair Growth Supplements. Viviscal's blend of ingredients (vitamin C, flax seed extract, and zinc, to name a few) help hair remain in its growth phase, called anagen.
Ezetimibe/atorvastatin (trade names Liptruzet, Atozet) is a cholesterol lowering combination drug. In the United States, it was approved in May 2013, by the Food and Drug Administration for the treatment of elevated low-density lipoprotein (LDL) in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet. [ 1 ]
Birdsall Medical Research Building located at the Mayo Clinic Jacksonville campus. Mayo Clinic Florida is a comprehensive medical center belonging to the Mayo Clinic in Jacksonville, Florida. It is one of three Mayo campuses along with Phoenix/Scottsdale, Arizona and Rochester, Minnesota. [1]
Health. Home & Garden
Guidelines by the American College of Cardiology and the American Heart Association recommend statin treatment for primary prevention of cardiovascular disease in adults with LDL cholesterol ≥ 190 mg/dL (4.9 mmol/L) or those with diabetes, age 40–75 with LDL-C 70–190 mg/dL (1.8–4.9 mmol/dL); or in those with a 10-year risk of developing ...